Anti-BRINP2 antibodies are used in the immunodetection of the protein BMP/retinoic acid inducible neural specific 2. In humans, the canonical protein has a reported length of 783 amino acid residues and a mass of 89 kDa. It has been described to be a secreted protein. Up to 2 different isoforms have been reported for this protein. A member of the BRINP protein family, BRINP2 is reported to inhibit neuronal cell proliferation by negative regulation of the cell cycle transition. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include DBCCR1-like protein 2, DBCCR1-like2, bone morphogenetic protein/retinoic acid inducible neural-specific 2, and BMP/retinoic acid-inducible neural-specific protein 2. BRINP2 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Some BRINP2 antibodies may have been used in research and have associated citations. ELISA is a widely used application for these antibodies. Immunocytochemistry, Immunofluorescence, and Immunohistochemistry are also common applications.